-
2022-501863-41-00
5
2023-11-13
Subjects With Stage IV or Advanced Stage IIIB/C Nonsquamous Non–Small
-
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2022-501024-20-00
5
2023-07-25
ER+/HER2- Early Breast Cancer
-
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
-
2023-509825-38-00
5
2022-12-01
Metastatic Non–Small Cell Lung Cancer
-
2024-512045-16-00
5
2022-08-18
EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer
-
2023-509372-41-00
5
2022-01-30
Multiple Sclerosis
-
2023-508248-23-00
5
2021-11-26
Non-alcoholic steatohepatitis (NASH)
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-510319-20-00
5
2021-10-21
Gastroesophageal Adenocarcinoma (GEA)
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2023-506752-24-00
5
2021-08-05
Locally recurrent inoperable or metastatic HR+/HER2- breast cancer, wh
-
2023-507961-24-00
5
2021-04-19
High-Risk HER2-Positive Breast Cancer
-
2023-506962-30-00
5
2021-03-29
Non-alcoholic steatohepatitis (NASH)
-
2023-509358-72-00
5
2020-11-23
Diffuse large B-cell lymphoma
-
2023-506827-26-00
5
2019-05-02
While it is well-established that long-term good glycaemic control wil
-
2023-507906-15-00
5
2019-01-30
Relapsing multiple sclerosis (RMS)
-
2023-510082-10-00
5
2022-09-05
Advanced non-small cell lung cancer harboring the KRAS G12C mutation
-
2023-508812-45-00
10
2024-11-11
Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures
-
2023-505755-40-00
4
2024-08-16
Chronic kidney disease
-
2022-502481-24-00
4
2024-05-23
Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)
-
2022-502000-73-00
5
2023-08-11
Focal Onset Seizures
-
2024-512646-42-00
4
2023-06-27
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
-
2022-501540-15-00
5
2023-04-25
Atopic Dermatitis